Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colonic Neoplasms × Vinorelbine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 83 Carcinoma, Non-Small-Cell Lung 49 Lung Neoplasms 22 Hodgkin Disease 15 Recurrence 10 Lymphoma 10 Prostatic Neoplasms 7 Triple Negative Breast Neoplasms 6 Neoplasm Metastasis 6 Neoplasms 5 Lymphoma, Non-Hodgkin 4 Lymphoma, Large B-Cell, Diffuse 4 Adenocarcinoma of Lung 4 Sarcoma 3 Rhabdomyosarcoma 3 Mesothelioma, Malignant 3 Mesothelioma 3 Breast Neoplasms, Male 3 Ovarian Neoplasms 2 Neuroblastoma 2 Multiple Myeloma 2 Melanoma 2 Lymphoma, Large-Cell, Anaplastic 2 HER2-negative Breast Cancer 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Brain Neoplasms 2 Advanced Breast Cancer 2 Waldenstrom Macroglobulinemia 1 Vinorelbine 1

Interventions

Fluorouracil 80 Oxaliplatin 73 Leucovorin 73 Irinotecan 68 Bevacizumab 45 Capecitabine 39 Cetuximab 36 Panitumumab 15 Folfox protocol 15 Floxuridine 11 Chemotherapy, Adjuvant 11 IFL protocol 9 Surgical Procedures, Operative 8 Neoadjuvant Therapy 8 Drug Therapy 8 trifluridine tipiracil drug combination 7 regorafenib 7 pembrolizumab 7 XELOX 7 Nivolumab 7 Radiotherapy 6 sargramostim 5 Trastuzumab 5 Melphalan 5 Immunohistochemistry 5 Dexamethasone 5 Celecoxib 5 Biopsy 5 tislelizumab 4 aflibercept 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03482362 2025-08-03

EORTC1616

The Netherlands Cancer Institute

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡